VOLUME 67   2006   SUPPLEMENT 5

Managing Nonadherence in Schizophrenia: The Role of Long-Acting Agents

CME Background Information
[PDF]

3 Epidemiology, Clinical Consequences, and Psychosocial Treatment of Nonadherence in Schizophrenia. Stefan Leucht and Stephan Heres
[Abstract] [PDF]

9 Review of Treatments That Can Ameliorate Nonadherence in Patients With Schizophrenia. John M. Kane
[Abstract] [PDF]

15 Risks Versus Benefits of Different Types of Long-Acting Injectable Antipsychotics. Joseph P. McEvoy
[Abstract] [PDF]

19 Relapse Prevention and Recovery in the Treatment of Schizophrenia. Nina R. Schooler
[Abstract] [PDF]

CME Section

24 Instructions and Posttest.
[PDF]

26 Registration Form and Evaluation.
[PDF]